PA
GWPH

Profund Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Profund Advisors’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,942
Closed -$421K – 1448
2021
Q1 		$421K Buy
1,942
+70
+4% +$13.2K 0.02% 710
2020
Q4 		$216K Sell
1,872
-1,301
-41% -$146K 0.01% 1058
2020
Q3 		$309K Sell
3,173
-593
-16% -$68.2K 0.02% 659
2020
Q2 		$462K Buy
3,766
+685
+22% +$77.7K 0.03% 418
2020
Q1 		$270K Sell
3,081
-941
-23% -$99.6K 0.02% 535
2019
Q4 		$421K Buy
4,022
+245
+6% +$27.5K 0.02% 702
2019
Q3 		$434K Sell
3,777
-502
-12% -$76.2K 0.02% 662
2019
Q2 		$738K Buy
4,279
+58
+1% +$10K 0.04% 475
2019
Q1 		$712K Buy
4,221
+689
+20% +$103K 0.03% 474
2018
Q4 		$344K Buy
+3,532
New +$463K 0.02% 671

Other funds holding GWPH

HDIM
Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Profund Advisors's GWPH Position: Q2 2021 in Review

Profund Advisors sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 1,942 shares — an estimated $421K sold.

Profund Advisors first reported a position in GWPH in Q4 2018 and held it in 10 quarters. The position peaked at $738K in Q2 2019. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • Profund Advisors reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Profund Advisors sold 1,942 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $421K.
  • Profund Advisors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2018 and held it in 10 quarters.
  • Profund Advisors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $738K in Q2 2019.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Profund Advisors's 13F filing for Q2 2021, filed 12 Aug 2021.